This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 
Introduction
The cell cytoskeleton is a network of different types of filaments on which molecular motors drive specific cargoes. Microtubules constitute one of the major cytoskeletal filaments and two types of motors, namely cytoplasmic dynein (later referred as dynein) and kinesins, use them as railroad tracks. Dynein is the only motor that drives cargoes towards the minus end of microtubules and, as such, appears responsible for most, if not all, the transport of cargoes from the cell periphery towards the cell body. Dynein is involved in the late phases of mitosis and its function has been extensively studied in neurons in which it appears crucial for retrograde transport in axons [1] and dendritic morphogenesis [2] .
Studies on dynein functions have been previously hampered by the lack of genetic tools. Indeed, the complexity of the motor, with numerous subunits yielding a 2 million Dalton molecular complex, render gain of function experiments currently impossible.
Conversely, embryos with ablated dynein heavy chain do not survive, showing the important functions of dynein during development [3] . However, mice with mildly compromised dynein function have been generated in 2003 by Hafezparast and collaborators [4] . These authors showed that two independent mouse strains generated by N-ethyl-N-nitrosourea-induced mutagenesis, Legs at odd angles (Loa) and Cramping 1 (Cra1, further referred to as Cra), harboured dominantly inherited missense point mutations in the cargo-binding domain of the dynein heavy chain 1. The Loa and Cra mutations did not appear to affect basic cellular functions of dynein such as mitosis. However, dynein mutation impaired the ability of dynein motors to sustain fast retrograde transport leading to a decreased efficiency of these motors in situations of cellular stress [4, 5] and retrograde transport in adult Loa/+ motor neurons was decreased [4, 5] . Homozygous mice die at birth but heterozygous mice are viable and present with a striking motor phenotype later ascribed to an early-onset proprioceptive sensory neuropathy [6] [7] [8] .
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Dynein dysfunction is a potential causal mechanism in neurodegenerative diseases, most notably in degenerative diseases of the striatum such as Huntington's disease (HD).
Indeed, huntingtin, the protein mutant in HD, and its associated protein HAP1 are binding partners of dynein and the activity of the dynein motor is positively regulated by wild type huntingtin, and strongly decreased by HD associated mutations of huntingtin [9, 10] . Our most recent studies showed that Cra/+ mice developped striatal atrophy and its expected behavioural and pathological consequences [11] . These results show that a point mutation in dynein is sufficient to lead to a pathology analogous to HD, although milder.
Besides central nervous system pathology, it is increasingly recognized that HD leads to a number of peripheral defects. Indeed, HD-associated mutations of huntingtin have systemic effects on energy metabolism. In particular, HD animal models develop defects in both brown and white adipose tissues leading to compromised lipolysis and thermogenesis [12] [13] [14] .
Whether dynein dysfunction leads to similar defects in the periphery remains unknown. We studied here the peripheral phenotype of dynein mutant mice and showed that dynein mutations compromise adipose tissue lipolysis and thermogenesis. We further provide evidence that the defect triggered by mutant dynein is due, at least in part, to increased oxidative stress in response to norepinephrine. Interestingly, protein levels of huntingtin were decreased in dynein mutant adipose tissue. This peripheral phenotype of dynein mutant mice is similar to that observed in various animal models of HD, lending further support for a functional link between huntingtin and dynein.
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Materials and methods

Animals
All the experiments were performed on male mice. Heterozygous Cra/+ mice were F1 generation of a C57Bl6/C3H crossing and were identified by tail DNA genotyping as described previously [4] . Wild-type littermates were used as controls. Heterozygous Loa/+ mice were in a pure C57Bl6 background. Mice were maintained at 23°C with a 12h light/dark cycle and had food and water ad libitum. For biochemical analysis, animals were sacrificed at the ages indicated in the figures (2, 4 and 8 months of age), and tissues were quickly dissected, frozen in liquid nitrogen and stored at -80°C until use. All animal experiments were performed under the supervision of authorized investigators and followed current EU regulations. For the high-fat diet (HFD) experiments, C57Bl6/C3H wild type mice were fed with chow diet supplemented with 20% (wt/wt) saturated fat.
RT-qPCR
Real time RT quantitative PCR was performed as described [7] . The relative levels of each RNA were normalized to the corresponding polymerase II RNA levels. Table S1 indicates the primers used for qPCR.
Histology
For adipose tissues histology, 24h post-fixed tissues were embedded in paraffin and cut on a microtome into slices of 16µm thickness. Sections were then deparaffinized and rehydrated before hematoxylin and eosin staining and then dehydrated for observation.
Leptin ELISA
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Leptin levels in serum were measured using an ELISA kit from Assay Pro (St Charles, MO, USA), following instructions of the manufacturer.
Indirect Calorimetry
We measured O 2 consumption and CO 2 production by using an open-circuit indirect calorimetry system (Klogor, Lannion, France) as described [15] . Energy expenditure was calculated during a 24h cold challenge at 7°C.
Body composition analysis
Carcasses were freeze-dried to constant mass and ground under liquid nitrogen to a fine homogenous powder kept at -20°C until chemical analysis. Samples were lyophilized for 48h just before analysis to eliminate any traces of water. Body lipid content was determined on duplicate samples by a solvent extraction procedure (chloroform/methanol; 2/1, v/v) adapted from Folch et al. [16] on 1 g of powder. The nitrogen content of the carcass was determined in triplicate using the Kjeldahl method on 100-150 mg of sample. Protein content was calculated as nitrogen content *6.25. Ash content was measured on duplicate 1-2-g samples after total combustion at 400°C for 24 h in a muffle furnace.
Western blot
white adipose tissue (WAT) pads were lysed and homogenized in a protein extraction buffer (PBS 1x, 0.1% SDS, 0.2% IGEPAL, 1% deoxycholate, 1x protease inhibitor cocktail and 1x phosphatase inhibitor) using a Potter homogenizer (VWR, Strasbourg, France). Protein quantification was carried out using a BCA assay kit (Interchim, Montlucon, France). Equal amounts of soluble proteins were denaturated by boiling, resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose A C C E P T E D M A N U S C R I P T Giles, United Kingdom). Results were quantified using imageJ software [17] .
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WAT explants and lipolysis assays
Epididymal WAT was dissected immediately after sacrifice, weighed, and minced with scissors in warm glucose-free Krebs-Ringer bicarbonate buffer, pH 7.4 containing 4% BSA.
Samples were incubated in 3 ml of buffer, pretreated or not with 1mM EHNA (erytro-9-(2-Hydroxy-3-nonyl) adenine hydrochloride, Sigma-Aldrich, Lyon France) or 10µM apocynin for 15 minutes, and then stimulated with 10µM isoproterenol or 10µM forskolin. Incubation medium was collected and assayed for glycerol content (Randox, Antrim, United Kingdom).
Glycerol levels were normalized to the corresponding tissue weight. Similar results were obtained by standardization with protein content (not shown).
Cell culture & treatments
3T3-L1 pre-adipocytes from ATCC (Manassas, USA) were grown until confluence in DMEM high glucose containing 10% FCS and 1% Penicillin/streptomycin in plates coated with 0.01% collagen. After two days of confluence, cells were differentiated into adipocytes by using DMEM high Glucose containing 10% FCS, 1% Penicillin/streptomycin, 1µM
Dexamethasone (Sigma-Aldrich, Lyon, France), 0.5mM of IBMX (3-isobutyl-1- 
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Statistical Analysis
Statistical comparisons were accomplished with the unpaired Student t test for comparison of two groups or ANOVA followed by the post hoc Newman-Keuls multiple comparisons test for multiple comparisons using PRISM version 2.0a software (GraphPad, San Diego, USA).
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3 Results
Hyperadiposity in the absence of energy imbalance in dynein mutant mice
To explore the potential role of dynein in adipocytes, we used mice heterozygous for the Cramping mutation (Cra/+) and the Legs at odd angles mutation (Loa/+). Both Loa/+ and Cra/+ mice showed increased weight of the white adipose tissue (WAT), including epididymal ( Fig. 1A, B ), interscapular and retroperitoneal (data not shown) fat pads.
Interestingly, increased mass of the fat pads was already significant at 2 months of age in Cra/+ animals and progressed with age. Adipocytes of Cra/+ and Loa/+ mice were larger than those of their corresponding +/+ mice at 8 months of age ( 2D ) were unchanged at 4 months of age. Furthermore, despite a trend towards increased lipid content, body composition of Cra/+ mice was not significantly different from that of wild type littermates at 4 months of age ( Table 1 ), suggesting that increased WAT deposition in these animals was compensated by decreased lipid content in other tissues. Altogether, dynein
mutant mice developed increased WAT deposition, in the absence of detectable energy imbalance.
Dynein is expressed in white adipose tissue
The increase in WAT accumulation suggested that dynein was involved in adipose tissue lipid metabolism. Such an involvement could be direct, through dynein action in adipocytes, or indirect through an impairment of CNS derived cues. If dynein has a function in lipid metabolism in WAT, it should first be expressed in this tissue. Indeed, mRNA levels of dynein heavy chain (DHC) were detectable in WAT and many other non-CNS tissues (Fig.3A) . Moreover, mutant DHC mRNA was observed in WAT of Cra/+ mice (Fig. 3B ).
Consistent with a role in lipid metabolism, DHC mRNA levels mildly but significantly increased after 3 weeks of high fat feeding in wild type mice, in a manner similar to perilipin mRNA (Fig. 3C ). In these experiments, the large increases in leptin mRNA (Fig. 3C ) and ATGL protein levels ( Fig. 3D) were consistent with efficient high fat feeding. Thus, dynein is expressed in adipocytes and regulated by high fat feeding, consistent with a function in lipid metabolism.
Dynein activity is required for norepinephrine-induced lipolysis
We next explored whether intrinsic defects in adipose tissue could be the cause of WAT accumulation in dynein mutant mice. The CNS mostly controls adipose tissue energy metabolism through activation of the sympathetic nervous system. Thus, if adipose tissues of Cra/+ mice were normal, and the increased adiposity of Cra/+ mice was the result of a "pure" CNS defect, their responses to norepinephrine should be similar to those of +/+ littermates.
Obesity is a confounding factor since development of obesity leads to blunted norepinephrine stimulated lipolysis [18] . To take this factor into account, we performed lipolysis experiments [19, 20] . Consistent with the results obtained in Cra/+ mice, basal lipolytic activity of WAT explants was unchanged by EHNA treatment while norepinephrine-stimulated lipolysis was completely blunted by EHNA coapplication (Fig. 4C ). To further document this point, we turned to the differentiated 3T3L1 cell line. In these cells, multiple lipid droplets are readily observable in the cytosol. The diameter of lipid droplets increased with EHNA treatment (Fig.   4D ), suggesting that dynein inhibition resulted in increased lipid storage in these cells.
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Furthermore, the decrease in droplet diameter elicited by isoproterenol treatment was potently inhibited by EHNA coapplication (Fig. 4D-E) . Thus, here again, dynein ATPase activity was required for adipocyte lipolysis.
3.4
Decreased lipolysis in dynein mutant WAT is associated with defectiveadrenergic signalling and due to increased oxidative stress
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To define the mechanisms underlying defective lipolysis in dynein mutant mice, we first studied -adrenergic signalling. The expressions of HSL and 2 adrenergic receptor were roughly normal in Cra/+ WAT (Fig. S1 ) and HSL protein levels were unchanged (Fig. 1E) .
Upon isoproterenol stimulation, WAT explants of Cra/+ mice showed blunted phosphorylation of HSL (Fig. 5A-B) . PKA activity, as evaluated by PKA substrate immunoreactivity, appeared however not significantly decreased (Fig. 5A-B) . Thus, dynein mutation triggered specifically abnormal PKA-mediated phosphorylation of HSL. However, direct adenylate cyclase activation by forskolin did not correct lipolysis deficiency (Fig. S2) ,
showing that the defect was independent of adenylate cyclase activation. Beta-adrenergic stimulation is known to modulate hydrogen peroxide production in adipocytes through PKAindependent pathways [21, 22] . Interestingly, hydrogen peroxide is known to inhibit norepinephrine induced-lipolysis [23, 24] and drugs interfering with the stability of microtubules, i.e. the dynein railroad tracks, are known to increase oxidative stress through NADPH oxidase activation [25, 26] . To directly study whether dynein mutation might lead to exacerbated oxidative stress, we measured H 2 O 2 production in response to norepinephrine stimulation. Consistent with previous works, H 2 O 2 was decreased in +/+ mice after norepinephrine stimulation (Fig. 6A ). H 2 O 2 was less in basal conditions in Cra/+ WAT explants, but potently stimulated after isoproterenol stimulation (Fig. 6A) . In WAT, oxidative stress is largely NADPH oxidase-dependent [27] and inhibition of NADPH oxidase with apocynin completely abolished H 2 O 2 production in both Cra/+ and +/+ mice (Fig. 6A) . To further document the existence of oxidative stress in Cra/+ WAT after norepinephrine stimulation, we treated WAT explants with the superoxide probe hydroethidine, which yields a nuclear fluorescent staining when superoxide is produced. Upon norepinephrine treatment, nuclei of Cra/+ WAT became brightly fluorescent, an event not observed in +/+ WAT explants (Fig. 6C) . We next measured the expression levels of NADPH oxidase subunits
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(gp47 and gp91) in WAT, as well as known antioxidant enzymes (SOD1 and glutathione peroxidase), and NFkappaB targets induced after oxidative stress (MCP-1 and IL6). All these genes were intensely up regulated in Cra/+ mice WAT at 4 months of age (Fig. 6B ). Although these upregulations do not necessarily mean that the corresponding proteins are increased, their coordinations provide indirect evidence of a potent antioxidant response. Last, in order to determine whether the defect in lipolysis was due to NADPH oxidase dependent oxidative stress, we treated WAT explants with apocynin and followed glycerol release upon isoproterenol stimulation. In these experiments, apocynin partially reverted Cra/+ defect in stimulated lipolysis (Fig. 6D ) and restored HSL phosphorylation (Fig. 6E) . Thus, dynein mutation limits stimulated lipolysis through a deregulation of endogenous oxidative stress.
Defective thermogenesis in dynein mutant mice
We next sought to determine whether the defect in lipolysis was restricted to the WAT. The interscapular brown adipose tissue (BAT) was paler (not shown), increased in size at 4 months of age (Fig. 7A ) and brown adipocytes accumulated fat as observed on histological sections of both Cra/+ and Loa/+ BAT (Fig. 7B ). This abnormal BAT phenotype was not due to transcriptional down regulation of UCP1 since mRNA levels of both UCP1 and PGC1 , one of its key activators, were unchanged at 4 months of age. Cra/+ mice displayed normal rectal temperature at 4 months of age but were hypothermic at 8 months of age (Fig. 8A ).
BAT function was however already abnormal at 4 months of age since a 4h cold challenge lead to hypothermia in Cra/+ mice in 4 and 8 months old mice (Fig. 8B and data not shown).
Furthermore, 4 months old Cra/+ mice were unable to increase energy expenditure upon cold at levels similar to +/+ mice (Fig. 8C) . We reasoned that the BAT defect lied also in a decreased response to norepinephrine. To test this hypothesis, we challenged Cra/+ mice with norepinephrine and measured their oxygen consumption (Fig. 8D ). The burst in oxygen
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Eschbach et al. 15/41 consumption after norepinephrine injection reflects sympathetic-like BAT activation. We observed that saline injection led to a transient increase in oxygen consumption during the first fifteen minutes after the injection, an increase probably due to the stress response induced by animal handling. However, the increase in oxygen consumption was sustained at least thirty minutes after norepinephrine injection (Fig. 8D) . Most interestingly, norepinephrineevoked oxygen consumption was strongly decreased in Cra/+ mice as compared with +/+ littermates (Fig. 8E) . In all, our results obtained in vivo, ex vivo and in vitro all converge to ascertain a key role to dynein in the control of adipose tissue lipolysis underlying lipid accumulation in the WAT and dysfunctional BAT-mediated thermogenesis. These defects are intrinsic to adipose tissues and independent of other CNS-linked consequences of dynein mutation.
Dynein mutation decreases levels of huntingtin in the WAT
The previous results obtained in WAT and BAT of dynein mutant animals are reminiscent of HD-associated defects observed in animal models of HD [13, 14, 28, 29] . To strengthen the analogy between the animal models we studied the expression levels of huntingtin and its associated protein HAP-1 [30, 31] in WAT of dynein mutant mice. Huntingtin, but not HAP-1, was expressed at significant levels in WAT (results not shown) and huntingtin mRNA levels appeared unchanged in WAT of 4 months old dynein mutant mice ( figure 9A ).
Interestingly however, protein levels of full length huntingtin were decreased in the WAT of 4 months old dynein mutant mice ( figure 9B ). Thus the dynein mutation led to decreased huntingtin protein levels in adult WAT.
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Discussion
The molecular motor dynein is ubiquitously expressed in adult animals, including in postmitotic cells, yet its role remains obscure in adult cells other than neurons. Our results document a previously unknown function for dynein in adipose tissue response to norepinephrine and lipolysis. The dynein-mutant associated defect in lipolysis was due to a dysfunctional -adrenergic signalling and appeared to be, at least in part, dependent on NADPH oxidase derived oxidative stress. These findings define dynein as a novel potential actor in energy homeostasis that could be of interest for type 2 diabetes. Furthermore, the peripheral phenotype described here in dynein mutant mice is strikingly similar to that of various animal models of Huntington's disease, further supporting the idea that dynein and huntingtin are functionnally linked.
The adipocyte phenotype of dynein mutant mice is independent of the central nervous system
Dynein function has been largely studied in the CNS, yet this motor is ubiquitously expressed.
We show here that dynein function is critical in the response of adipose tissues to norepinephrine. This requirement is due to a function of dynein in adipocytes themselves and is not a secondary consequence of a CNS abnormality in dynein mutant mice. Several lines of evidence support this claim. First, dynein is expressed in adipose tissue and regulated in a manner consistent with a function in lipid metabolism. Second, the WAT phenotype occurs in early adulthood, long before neurodegeneration was thought to occur [4] . Third, the defect in lipolysis is recapitulated ex vivo, in the absence of CNS-derived cues and in vitro upon chemical inhibition of dynein. Fourth, this defect occured in mice with normal energy balance, most notably with normal energy intake and energy expenditure. This however does
A C C E P T E D M A N U S C R I P T ACCEPTED MANUSCRIPT
Eschbach et al. 17/41 not fully exclude a CNS influence on the adipose phenotype. The generation of conditional knock out animals will be a necessary step to solve this question.
Dynein is required at several steps in lipid metabolism
The dynein motor has been firmly established as a major actor in lipid droplet formation [32] [33] [34] [35] [36] . First, an RNAi-based functional screen revealed that dynein knockdown resulted in strikingly diminished lipid accumulation in drosophila cells [36] . Furthermore, dynein is a component of mammalian lipid droplets [32] and appears required for the formation of these organelles [32] [33] [34] . Indeed, chemical inhibition of dynein in differentiated 3T3L1 cells increased the size of lipid droplets not only in isoproterenol treated cells, but also in basal conditions, consistent with dynein involvement in lipid droplet trafficking [32, 34] . This function of dynein resembles that demonstrated for perilipin [37] or caveolin 1 [38] , both of these proteins being involved in lipid droplet formation in adipocytes. Nevertheless, and contrary to either perilipin -/-or caveolin1 -/-mice, dynein mutant mice were not lean, but showed strikingly enhanced adipose fat pads with strongly increased WAT weight long before obesity was observed and WAT explants of dynein mutant mice did not show changes in basal lipolysis. This suggests that lipid droplet formation and protection of lipids from lipases was not changed by the dynein mutation, consistent with the fact that dynein mutation does not significantly impair housekeeping functions of dynein but rather decreases dynein transport upon cellular stress [4] . Despite normal basal lipolysis, Cra/+ WAT showed decreased ability to provide an adequate lipolytic response to norepinephrine. Importantly, BAT norepinephrine response was also defective and underlied the defect in thermogenesis observed in mutant animals. Thus, a first important result of this study is that, besides its known role in lipid droplet formation, dynein is involved in adipose tissue response to norepinephrine.
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Mechanisms underlying dynein involvement in stimulated lipolysis
We next defined the mechanisms underlying dynein function in stimulated lipolysis. First, dynein mutation blunted the effects of norepinephrine on HSL phosphorylation. This signalling defect was not due to strongly impaired PKA activation but rather to a selective inhibition of PKA-mediated HSL phosphorylation. Two lines of evidence suggested that dynein did not impair the classical cAMP/PKA axis after norepinephrine stimulation: first, PKA activity appeared only mildly decreased in Cra/+ WAT after stimulation. Second, direct activation of adenylate cyclase by forskolin did not correct the lipolysis defect, suggesting that the defect was either downstream adenylate cyclase or affecting other pathways elicited by the beta-adrenergic receptors. A number of accessory pathways have been described after beta-adrenergic stimulation. Among them, we chose to focus on NADPH oxidase oxidative stress production. Indeed, NADPH oxidase-dependent oxidative stress has been shown to participate in several aspects of the transduction pathway of beta-adrenergic receptors, independently of PKA [22, 39] although whether norepinephrine actually increases [22, 24] or decreases [21] oxidative stress production in adipocytes remains controversial. Furthermore, NADPH activation has been shown to be downstream the cellular effects of microtubules depolymerising drugs [25, 26] . Here, we observed that norepinephrine decreased H2O2 production in wild type adipocytes, a result similar to Krieger and collaborators [21] .
Contrasting with this, H2O2 production was potently increased in Cra/+ adipocytes suggesting that an inhibitory mechanism was lost in dynein mutant WAT. Consistent with increased oxidative stress, superoxide production in response to norepinephrine was noticeable in dynein mutant adipocytes and we observed an oxidative stress-like transcriptional fingerprint in WAT. Interestingly, previous work has indicated that NADPH oxidase inhibition after beta-adrenergic stimulation was due to the beta-gamma subunits of
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G(s) protein [21] and that the dynein light chain Tctex1 is known to modulate G protein beta gamma subunits [40] . Another dynein light chain, LC8, was involved in the attenuation of NFkappaB signalling after NADPH oxidase stimulation by oxidative stress [41] . Whether dynein mutation leads to abnormal function of Tctex1 and/or LC8 underlying increased NADPH oxidase dependent oxidative stress in Cra/+ WAT will require further work. Our study however shows that NADPH-oxidase ROS production was responsible for at least part of the inhibition of lipolysis since HSL phosphorylation was restored by apocynin, a specific NAPDH oxidase inhibitor [42] and since apocynin treatment also reverted the defect in lipolysis.
Potential consequences for Huntington's disease
Dynein is especially known for its involvement in neurodegenerative diseases, especially in motor neuron diseases and in Huntington's disease (HD). More specifically for HD, mutant
Huntingtin decreases dynein activity and this might be crucial for the pathogenesis [9, 10] .
Interestingly, our current results show that huntingtin protein levels are decreased in dynein mutant mice. The mechanisms underlying this defect, as well as its relationship with the phenotype described here are still elusive. It is striking to note that a very similar metabolic phenotype was observed in HD animal models (for review see [43] [44] [45] ). Notably, R6/2 transgenic mice show increased adiposity [14, 28] , in the absence of obesity [14, 28, 29] .
Adipose tissue of R6/2 mice show decreased isoproterenol stimulated lipolysis [14] and brown adipose tissue mediated thermogenesis was profoundly impaired [13] . In all, the peripheral phenotype observed in R6/2 mice was strikingly similar to dynein mutant phenotype suggesting that common pathways, for instance through modification of PGC1alpha function [13, 28] , might be at work upon dynein mutation and mutant huntingtin 
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Conclusions
In all, our study provides the first in vivo evidence of a key role for a molecular motor in adipose tissue physiology through its regulatory role on reactive oxygen species production after norepinephrine stimulation. Exploration of the contribution of dynein and its interacting proteins to human diabetes and metabolic syndrome is warranted. Our study also provides further support for decreased dynein function as a potential mechanism of HD. M A N U S C R I P T minutes (light grey) were used for the quantification in E. ***, p<0.001 vs. condition shown.
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